BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8569815)

  • 1. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole.
    Van Gerven F; Odds FC
    Mycoses; 1995; 38(9-10):389-93. PubMed ID: 8569815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Malassezia furfur against azole compounds.
    Schmidt A; Rühl-Hörster B
    Mycoses; 1996; 39(7-8):309-12. PubMed ID: 9009652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group.
    Alomar A; Videla S; Delgadillo J; Gich I; Izquierdo I; Forn J
    Dermatology; 1995; 190(4):295-300. PubMed ID: 7655109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K; Hosaka J; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
    García Rafanell J; Dronda MA; Merlos M; Forn J; Torres JM; Zapatero MI; Basi N
    Arzneimittelforschung; 1992 Jun; 42(6):836-40. PubMed ID: 1418042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses.
    Romaguera C; Herrero E; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):754-6. PubMed ID: 1627200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus.
    Carrilo-Muñoz AJ; Tur C; Torres J
    J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream.
    del Palacio A; Cuétara S; Pérez A; Garau M; Calvo T; Sánchez-Alor G
    Mycoses; 1999; 42(11-12):649-55. PubMed ID: 10680442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses.
    Alomar C; Bassas S; Casas M; Crespo V; Ferrándiz C; Fonseca E; Hernández B; Noguera J; Pedragosa R; Peyrí J
    Arzneimittelforschung; 1992 May; 42(5A):767-73. PubMed ID: 1627204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized comparative trial: flutrimazole 1% solution versus bifonazole 1% solution once daily in dermatomycoses.
    del Palacio ; Cuétara S; Izquierdo I; Videla S; Delgadillo J; Boncompte E; Rodríguez Noriega A
    Mycoses; 1995; 38(9-10):395-403. PubMed ID: 8569816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro sensitivity of Malassezia spp. to various antimycotics.
    Lorenzini R; Mercantini R; De Bernardis F
    Drugs Exp Clin Res; 1985; 11(6):393-5. PubMed ID: 3836136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of sertaconazole against Malassezia furfur and pachydermatis in different culture media.
    Palacin C; Tarragó C; Ortiz JA
    Methods Find Exp Clin Pharmacol; 1998; 20(6):451-5. PubMed ID: 9789868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antifungal activity of amorolfine against Malassezia species].
    Uchida K; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 Sep; 44(9):1013-9. PubMed ID: 1960851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species.
    Hammer KA; Carson CF; Riley TV
    Antimicrob Agents Chemother; 2000 Feb; 44(2):467-9. PubMed ID: 10639388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertaconazole antifungal profile determined by a microdilution method versus nine topical substances against dermatophyte fungi.
    Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
    Chemotherapy; 2012; 58(5):399-404. PubMed ID: 23296325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
    Rigopoulos D; Gregoriou S; Kontochristopoulos G; Ifantides A; Katsambas A
    Mycoses; 2007 May; 50(3):193-5. PubMed ID: 17472615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.